CompletedNCT01267188
NBI-98854 for adults with tardive dyskinesia
This study is completed in Canada. It focuses on adults with tardive dyskinesia.
In TorontoSchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT02777931
NFC-1 for ADHD
This study is completed in the United States. It is testing NFC-1 for ADHD.
In BaltimoreADHDDrugFrom 12 Years to 17 Years
CompletedNCT00467428
NS2359 for ADHD
This study is completed in the United States. It is testing NS2359 for ADHD.
In BostonADHDDrugFrom 18 Years to 55 Years
CompletedNCT00266630
Olanzapine for Bipolarity
This study is completed in Japan. It is testing olanzapine for Bipolarity.
Multiple locations, including AkitaBipolarityDrugFrom 20 Years to 65 Years
CompletedNCT00190736
Once-Daily Atomoxetine Hydrochloride for ADHD
This study is completed in the United States. It is testing Once-Daily Atomoxetine Hydrochloride for ADHD.
Multiple locations, including LafayetteADHDDrugFrom 18 Years to 54 Years
CompletedNCT01157585
Paliperidone ER for Schizophrenia
This study is completed in South Korea. It is testing Paliperidone ER for Schizophrenia.
Multiple locations, including AnsanSchizophreniaDrugFrom 18 Years to 59 Years
CompletedEUCTR 2017-002263-17
Passiflora Compose for anxiety
This study is completed in France. It is testing passiflora Compose for anxiety.
In FranceAnxietyOther
CompletedNCT04531982
Pimavanserin for schizophrenia
This study is completed in Argentina, in Bulgaria, in Croatia, .... It is testing pimavanserin for schizophrenia.
Multiple locations, including Buenos AiresSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT02970305
Pimavanserin for schizophrenia
This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.
Multiple locations, including PhoenixSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT04670081
Psilocybin for depression
This study is completed in Germany. It is testing psilocybin for depression.
Multiple locations, including BerlinDepressionDrugFrom 25 Years to 65 Years
CompletedNCT00254774
Quetiapine Compared With Valproate for Bipolarity
This study is completed in Germany. It is testing quetiapine Compared With Valproate for Bipolarity.
Multiple locations, including BerlinBipolarityDrugFrom 18 Years to 65 Years
CompletedNCT00114686
Quetiapine Fumarate (SEROQUEL®) for Bipolarity
This study is completed in the United States. It is testing Quetiapine Fumarate (SEROQUEL®) for Bipolarity.
Multiple locations, including CerritosBipolarityDrugFrom 21 Years to 60 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.